Organelle biogenesis requires proper transport of proteins from their site of synthesis to their target subcellular compartment 1-3 . Lysosomal enzymes are synthesized in the endoplasmic reticulum (ER) and traffic through the Golgi complex before being transferred to the endolysosomal system 4-6 , but how they are transferred from the ER to the Golgi is unknown. Here, we show that ER-to-Golgi transfer of lysosomal enzymes requires CLN8, an ER-associated membrane protein whose loss of function leads to the lysosomal storage disorder, neuronal ceroid lipofuscinosis 8 (a type of Batten disease) 7 . ER-to-Golgi trafficking of CLN8 requires interaction with the COPII and COPI machineries via specific export and retrieval signals localized in the cytosolic carboxy terminus of CLN8. CLN8 deficiency leads to depletion of soluble enzymes in the lysosome, thus impairing lysosome biogenesis. Binding to lysosomal enzymes requires the second luminal loop of CLN8 and is abolished by some disease-causing mutations within this region. Our data establish an unanticipated example of an ER receptor serving the biogenesis of an organelle and indicate that impaired transport of lysosomal enzymes underlies Batten disease caused by mutations in CLN8.
between the expression of genes encoding human ER-resident proteins (hereafter referred to as ER genes) and that of genes encoding lysosomal enzymes (lysosomal genes). We used sets of expression microarray data from a wide variety of dynamic states following chemical, biological or genetic perturbation, an established approach for studying lysosomal regulation 8, 9 . We found that the expression of ~10% of ER genes correlates with that of lysosomal genes (Fig. 1a) , notably including ER genes participating in the maturation of lysosomal proteins, such as oligosaccharyltransferase genes, γ -secretase complex genes and sulfatase-modifying factor genes (Supplementary Table 2 ). Four ER genes with expression correlated to lysosomal genes encode candidate cargo receptors or proteins that are possibly involved in vesicular transport: CLN8, TMED4, TMED9 and LMF1 (Supplementary Table 2 ). To determine whether any of these four candidate receptors interacts with lysosomal enzymes, we employed a bimolecular fluorescence complementation (BiFC) system based on a split yellow fluorescent protein (YFP) variant 12 . We generated two libraries of plasmids encoding lysosomal enzymes (n = 53) fused either to YFP amino-terminal fragment (Y1) or to YFP carboxy-terminal fragment (Y2), respectively, and two libraries of plasmids encoding the four candidate cargo receptors with Y1 or Y2 tags, which we confirmed localize to the ER ( Supplementary Fig. 1a ). A DQ-Red BSA assay to measure the proteolytic activity of the lysosome showed that the overexpression of candidate ER cargo receptors did not alter lysosomal degradation capability ( Fig. 1b ). Confocal microscopy of HeLa cells co-transfected with CLN8, TMED4, TMED9 or LMF1 plasmids and pools of plasmids expressing lysosomal enzymes showed that only the Y2-CLN8 construct consistently interacted with all of the pools ( Fig. 1c and Supplementary Fig. 1b ). Pairwise co-transfection of Y2-CLN8 with lysosomal enzymes followed by quantification through flow cytometry showed that CLN8 interacted with two-thirds of the lysosomal enzymes, but not with non-lysosomal proteins that we tested as a control ( Fig. 1d and Supplementary  Fig. 1c ). Co-immunoprecipitation (co-IP) of CLN8-Myc followed by immunoblotting confirmed the interactions detected by the BiFC assay ( Fig. 1e ).
CLN8 is a ubiquitously expressed ER membrane protein of unknown function that forms homodimers 13 . CLN8 deficiency 7, 14 . It is worth noting that, although most lysosomal storage disorders are caused by deficiency of lysosomal enzymes, CLN8 is not in this category.
To determine whether CLN8 is required for proper delivery of lysosomal enzymes, we analysed the Cln8 mnd mouse strain, which bears an early frameshift mutation in Cln8 that causes CLN8 protein deficiency and features resembling those seen in Batten disease 7 .
To focus on the primary molecular insult caused by CLN8 deficiency, we analysed Cln8 mnd mice at the pre-symptomatic age of 2 months 15 . We obtained subcellular fractions enriched for lysosomes from the livers of Cln8 mnd mice (knockout) and age-matched wild-type (WT) mice using a Nycodenz gradient ( Supplementary  Fig. 2a -c). Comparison of lysosome-enriched fractions by liquid chromatography-tandem mass spectrometry (LC-MS/MS) showed that Cln8 mnd samples had lower levels of lysosomal enzymes than WT samples ( Fig. 2a and Supplementary Fig. 2d ). Gene 
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NatuRE CELL BIOLOGy set enrichment analysis (GSEA) of proteomic data showed that lysosomal enzymes were specifically depleted in Cln8 mnd samples ( Fig. 2b and Supplementary Table 3 ), whereas the sets of lysosomal membrane proteins-which are transported to lysosomes via a different route than lysosomal soluble proteins 5 -and mitochondrial matrix proteins (used as a control) showed no overall variation (Supplementary Fig. 2e and Supplementary Tables 4 and 5 ). Immunoblot analysis confirmed lower levels of tested lysosomal enzymes in the lysosome-enriched fraction from Cln8 mnd mice ( Fig. 2c ). Accordingly, the lysosome-enriched fraction from Cln8 mnd mice showed reduced activity of several tested lysosomal enzymes ( Supplementary Fig. 2f ). However, the amounts of transcripts 
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for lysosomal enzymes in the samples from Cln8 mnd mice were unchanged or slightly increased ( Supplementary Fig. 2g ), indicating that the reduction of lysosomal enzymes occurs posttranscriptionally. Immunohistochemical analysis of cortical and cerebellar sections from Cln8 mnd mice confirmed a reduction of enzyme signals ( Supplementary Fig. 3a ). Confocal microscopy revealed a reduction of enzyme signals at lysosomes ( Fig. 2d and Supplementary Fig. 3b ) and sparse spots of residual enzymes overlapping with the ER ( Supplementary Fig. 4a ), indicating a maturation defect. Confocal microscopy and immunoblot analyses of fibroblasts derived from patients with mutations in CLN8 (ref. 16 ) showed impaired colocalization of tripeptidylpeptidase 1 (TPP1) with the lysosomal marker LAMP1 ( Fig. 2e and Supplementary Fig. 4b ) and depletion of tested lysosomal enzymes ( Supplementary Fig. 4c ). Cargo receptors that traffic from the ER to the Golgi complex can be retrieved to the ER through interaction with COPI, a protein complex that serves as the coatomer of vesicles involved in retrograde transport 17, 18 . COPI recognizes a KKXX retrieval signal at the C terminus of its target cargo receptors 19, 20 and mediates a very Letters NatuRE CELL BIOLOGy efficient retrieval that localizes the cargo receptors predominantly to the ER (and only minimally to the Golgi complex) 21, 22 . Several lines of evidence indicated that CLN8 is retrieved from the Golgi complex to the ER in a COPI-dependent manner. First, CLN8 carries a terminal KKXX signal 23 and localizes primarily to the ER ( Supplementary  Fig. 4d ). Second, cell treatment with CBM, a drug that inhibits COPI-mediated vesicular transport and thereby abolishes the retrieval of cargo receptors 24 , increased localization of CLN8 to the Golgi complex ( Fig. 3a) , as did mutating the KKXX sequence of CLN8 (ref. 23 ) (Fig. 3b ). Third, BiFC and co-IP experiments showed that CLN8 interacts with the COPI complex and this interaction could be disrupted either by mutating the KKXX signal of CLN8 or by CBM Letters NatuRE CELL BIOLOGy (Fig. 3c,d and Supplementary Fig. 4e ). To test whether CLN8 determines the localization of newly synthesized lysosomal enzymes, we took advantage of the fact that, in the BiFC assay, interacting proteins form a stable complex 12 whose localization can be monitored by confocal microscopy. Consistent with the above results, mutagenesis of CLN8's KKXX retrieval signal and CBM inhibition of COPI-mediated retrieval each led to increased localization of the enzyme-Y1/Y2-CLN8 complex to the Golgi (Fig. 3e ). We next investigated the association of CLN8 with COPII, the coatomer of vesicles involved in ER-to-Golgi anterograde traffic 25 . COPII interacts with cargo receptors via its Sec24 subunits, which recognize specific cytosolic ER export signals within the cargo receptor protein sequence. The cytosolic tail of CLN8 contains a 261 VDWNF 265 motif that overlaps with the Φ XΦ XΦ ER export signal 26 . Lysates derived from HeLa cells expressing Myctagged Sec24A, Sec24B, Sec24C or Sec24D were subjected to pull down using the cytosolic tail of CLN8 fused with glutathione S-transferase (GST). Immunoblotting revealed interaction of CLN8 with Sec24a and Sec24c; this interaction was abolished by mutations in the 261 VDWNF 265 motif ( Fig. 3f and Supplementary Fig. 4f ). Mutagenesis of this motif severely diminished Golgi localization of CLN8 with mutated ER retrieval signal ( Fig. 3g and Supplementary  Fig. 4g ), thus confirming that the 261 VDWNF 265 motif is the CLN8's signal for COPII-mediated ER export. Interestingly, this motif is disrupted by a known pathogenic mutation (W263C; http://www. ucl.ac.uk/ncl/).
Metabolic radiolabelling experiments using CLN8-deficient cells (CLN8 −/− ) obtained by clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) genome editing ( Supplementary Fig. 5a ,b) showed that CLN8 deficiency delays maturation of lysosomal enzymes ( Fig. 4a-d) , which was rescued by CLN8 re-expression ( Supplementary Fig. 5c ). Additional experiments showed that CLN8 deficiency leads to faster clearance of lysosomal enzymes ( Fig. 4e-g) , supporting the notion that lysosomal enzymes have a maturation defect in the absence of CLN8. We tested whether ER-associated protein degradation (ERAD) inhibition would increase the amounts of mature enzymes in CLN8 −/− cells. Immunoblot and metabolic radiolabelling experiments indicated that ERAD is responsible for the enhanced degradation of lysosomal cargo proteins in the absence of CLN8; however, ERAD inhibition did not translate into an increased trafficking and maturation of enzymes in the absence of CLN8 ( Supplementary  Fig. 5d,e ). These data indicated that receptor-mediated transport is critical for the ER exit of these cargo proteins.
CLN8 is a polytopic membrane protein with five transmembrane domains and two lumen-facing loops 27 (Fig. 5a ). To gain insight into the interaction of CLN8 with lysosomal cargo, we analysed the evolutionary profile of CLN8 and found that the second luminal loop is the most evolutionary-constrained region of CLN8 (Fig. 5c ). Out of ~15 pathogenic missense mutations and single amino acid deletions detected in CLN8 patients (http://www.ucl.ac.uk/ncl/), 6 map within this loop (Fig. 5a,c) . Thus, we hypothesized that the second luminal loop is involved in CLN8's interaction with lysosomal enzymes. To test this hypothesis, we generated a CLN8 construct lacking the second loop (CLN8Δ L; Fig. 5b ) and used it in interaction studies with lysosomal enzymes. We first verified that the CLN8Δ L protein colocalizes with full-length CLN8 (Fig. 5d) , can traffic to the Golgi (Fig. 5e ) and retains BiFC competence (Fig. 5f ). Subsequent pairwise BiFC analyses showed that deletion of the second CLN8 loop disrupted the interaction with tested lysosomal enzymes (Fig. 5g,h) . Next, we used BiFC/flow cytometry to test the effects of five pathogenic mutations mapped in the second loop and found that four out of five severely reduced the interaction with lysosomal cargos (Fig. 5i,j) . Thus, the second luminal loop of CLN8 is necessary for CLN8 interaction with lysosomal enzymes, and some CLN8 pathogenic mutations disrupt these interactions.
Our results reveal an unanticipated mechanism for maturation of lysosomal enzymes that requires a specific receptor, CLN8, to transport them from the ER to the Golgi complex. This provides an example of organelle biogenesis that is controlled by an ER cargo receptor. In the absence of CLN8, the trafficking of lysosomal enzymes is disrupted, suggesting that the pathogenesis of Batten disease caused by mutations in CLN8 is rooted in impaired lysosome biogenesis. A larger implication of our results is that CLN8 control of lysosomal homeostasis could be explored as a potential target for therapeutic intervention in disease conditions, such as certain types of cancer, that are characterized by aberrant or unrestricted lysosomal activation 28,29 .
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NatuRE CELL BIOLOGy Supplementary Table 6 . pcDNA3[nYFP1-CLN8] and pcDNA3[nYFP2-CLN8] constructs were generated by inserting the signal peptide sequence of calreticulin upstream of the YFP sequence to assure ER import of the constructs and a lumen-facing YFP tag. Cells were grown at 37 °C in 5% CO 2 in DMEM (Euroclone), supplemented with 1% glutamine and Pen-Strep. HeLa cells and biopsied fibroblasts were grown with 10% and 20% heat-inactivated FBS (Hyclone), respectively. Transfection of full-length cDNAs in HeLa cells was performed using Lipofectamine LTX Transfection Reagent (Invitrogen), according to the manufacturer's directions. Short interfering RNA (siRNA) oligonucleotides were purchased from Thermo Scientific. CLN8 expression was knocked down using ON-TARGETplus SMARTpool (L-013304-00-0010). Non-silencing control siRNA analysis was performed using ON-TARGETplus Non-targeting Pool (D-001810- [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Transfection of siRNAs (50 nM, 24 h after cell plating) in HeLa cells was performed by using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions. CLN8dK constructs, CLN8 constructs harbouring NCL-related mutations, and glycosylation mutants of cathepsin D (CTSD), Nacetylgalactosamine-6-sulfatase (GALNS) and ganglioside GM2 activator (GM2A) were obtained by using the QuikChange XLII Site-directed Mutagenesis kit (Invitrogen), according to the manufacturer's directions. CLN8Δ L was obtained by removing codons for amino acids 155-222 using the Q5 Site-Directed Mutagenesis kit (New England Biolabs), according to the manufacturer's directions. The oligonucleotides used for site-directed mutagenesis are reported in Supplementary  Table 6 . All of the cells used in this study were not contaminated. The assessment of the contamination was performed using LookOut Mycoplasma PCR Detection Kit (Sigma).
Confocal microscopy.
Transfected cells were grown on glass coverslips for 24-48 h, washed with PBS and fixed with 4% paraformaldehyde (PFA; Sigma-Aldrich) for 15 min. After quenching PFA with 50 mM NH 4 Cl for 15 min, cells were washed with PBS and permeabilized in blocking buffer (0.1% saponin/10% FBS in PBS) for 1 h. Coverslips were then incubated overnight with appropriate primary antibodies and for 1 h with Alexa-Fluor-conjugated secondary antibodies (Supplementary Table 7 ). Coverslips were mounted on glass slides with Vectashield DAPI (Vector Laboratories). Images were taken with a Leica TCS SP2 AOBS confocal microscope using a Plan-Neofluar 20° or 63°ø immersion objective (Carl Zeiss). For quantitative colocalization analysis of BiFC interactions with organellar markers, ten independent pictures were acquired and analysed with the Coloc2 plugin in Fiji software. Confocal microscopy analyses of mice brains and human fibroblasts were performed using AlexaFluor 633 (far-red) to avoid overlap with autofluorescent ceroid lipopigments 30 . To quantify lysosomal degradation capacity, cells were incubated with 10 μ g ml −1 of DQ-Red BSA for 24 h (37 °C, 5% CO 2 ) and subsequently transfected with pcDNA, CLN8-Y2, LMF1-Y2, Y2-TMED4 or Y2-TMED9 for an additional 24 h. Immunostaining to identify transfected cells was carried out with anti-GFP antibody (Supplementary Table 7 ). Quantification of corrected total cell fluorescence of the DQ-Red BSA signal from GFP-positive cells was performed as previously described 31 .
Flow cytometry analysis. HeLa cells were plated in 24-well plates and, after 24 h, transfected with 200 ng YFP1-tagged and 200 ng YFP2-tagged constructs, in combination with 200 ng Ruby plasmid that was used as a reference for transfection efficiency. After 48 h, the fluorescence of 10,000 cells per sample was determined by flow cytometry using the BD LSRFortessa Cell Analyzer (BD Biosciences) with the HTS autosampler device. Only Ruby-positive cells were considered for the subsequent analysis of reconstituted YFP signal quantification.
Generation of CLN8 knockout cells. CRISPR-Cas9 genome editing was used to introduce a deletion in the CLN8 gene in HeLa cells, specifically, to delete exon 2, which contains the translation start codon ( Supplementary Fig. 5a ). To this end, two complementary oligonucleotide couples ( Supplementary Table 6 ), coding for a guide RNA upstream of a protospacer adjacent motif site in exon 2 of CLN8, were designed using the online CRISPR design tool (http://crispr.mit.edu). The two oligos were annealed and subsequently cloned into the pX458 plasmid 32 , followed by Sanger sequencing of the insert to confirm the correct sequence. HeLa cells were transfected with 2 µ g plasmid and split in a 96-well plate by single-cell deposition. After 3-4 weeks, DNA was isolated from the expanded single colonies and used in PCRs using oligos to amplify exon 2 of CLN8 with CloneAmp HiFi PCR Premix (Clontech) according to the manufacturer's instructions; clones that were unable to produce an amplicon were subsequently Sanger sequenced to confirm deletion of exon 2. CLN8 −/− cells were analysed by quantitative real-time PCR (qrtPCR) to confirm the absence of CLN8 RNA expression and used for further experiments.
Lentivirus generation, infection and expression. CLN8, GALNS and TPP1 fullcoding sequences were PCR amplified and cloned into the pINDUCER20 lentiviral vector by InFusion procedure after removal of the ccdB site, and insertion of a 3× Flag cassette and a SalI restriction site were introduced into the vectors' backbone, obtaining the pIND20-CLN8-3× Flag, pIND20-GALNS-3× Flag and pIND20-TPP1-3× Flag constructs. The oligonucleotides used for CLN8, TPP1 and GALNS cloning into the pINDUCER20 vector are shown in Supplementary Table 6 . Lentiviral vectors and their respective packaging vectors (psPAX2 and pMD2G) were cotransfected into HEK293T cells in a 4/3/1 molar ratio, respectively. Media were changed 16 h following transfection to low-volume media (5 ml for a 10-cm dish). Media were collected at 48 h following transfection, replaced with fresh media (5 ml) and collected again at 72 h. Viral supernatant was cleared from cell debris via centrifugation (10 min at 4,000 r.p.m.) as well as filtration through a 0.45-µ M polyethersulfone membrane (VWR). Viruses were added to the receiving cells in complete media with polybrene (8ug ml −1 ) and incubated at 37 °C for 48 h. Cells were selected for more than 1 week in geneticin-containing medium (G418, 400 µ g ml −1 ). Expression of the transgenes was induced with 2 μ g ml −1 doxycycline. Binding assay for the interaction of CLN8 with Sec24 proteins. The cytosolic tail of CLN8 (nucleotides 739-861 of CLN8's open reading frame) with or without the WdK mutation was amplified from the CLN8-Y2 or CLN8WdK-Y2 construct, respectively, and cloned in the pGEX-2T vector, obtaining the GST-CLN8dK and GST-CLN8WdK constructs. The oligonucleotide sequences are reported in Supplementary Table 6 . The GST-CLN8dK and GST-CLN8WdK constructs were transformed individually in Rosetta(DE3) cells and protein expression was induced with 0.5 mM isopropyl-β -d-thiogalactoside for 4 h at 37 °C. The bacteria were lysed using sonication and 0.5% Triton X-100 in PBS supplemented with complete, EDTA-free protease inhibitor (Roche). The supernatant was then loaded onto a pre-packed column with 1 ml glutathione sepharose 4B resin (GE Healthcare). Elution was performed using a step gradient of 10 mM glutathione in 50 mM Tris-HCl pH 8.0. Fractions with > 80% purity were combined and dialysed overnight in PBS at 4 °C. A total of 0.5 μ g purified protein, as determined by absorbance at 280 nm (extinction coefficient calculated using the ExPASy ProtParam tool), was incubated overnight at 4 °C with 5 μ l glutathione sepharose 4B resin (GE Healthcare), for each individual experiment. Cell lysates from HeLa cells expressing Myc-tagged Sec24A, Sec24B, Sec24C or Sec24D were incubated for 16 h with GST-CLN8dK or GST-CLN8WdK, immobilized on the resin. Glutathione beads were pelleted and washed three times with NP-40 buffer. Sec24 proteins bound to the resin were detected by immunoblotting using the anti-Myc antibody.
Cycloheximide assay. CTSD-YFP2 and TPP1-YFP2 constructs were transfected 24 h after CLN8 siRNA transfection in HeLa cells, and 100 μ g ml −1 cycloheximide (Sigma) were added after 24 h of incubation (corresponding to 48 h after siRNA transfection). Cells were harvested 0, 90, 180 and 270 min after treatment for analysis by western blotting.
qrtPCR. RNA samples were obtained using the RNeasy kit (Qiagen) according to the manufacturer's instructions. RNA was quantified using the Nano-Drop 8000 (Thermo Fisher). cDNA was synthesized using the QuantiTect Reverse Transcription kit (Qiagen). Real-time quantitative RT-PCR on cDNAs was carried out with iTaq Universal SYBR Green Supermix using the C1000 Thermal Cycler detection system (Bio-Rad) with the following conditions: 95 ºC for 5 min; (95 ºC for 10 s; 60 ºC for 10 s; 72 ºC for 15 s) × 40 cycles. For expression studies, the qrtPCR results were normalized to an internal control (Cyclophilin). The oligonucleotide sequences used are reported in Supplementary Table 6 .
Mice. The CLN8 mnd mouse line was purchased from the Jackson Laboratory (species: C57/B6, strain: B6.KB2-Cln8mnd/MsrJ). All of the mice used in this 1 nature research | reporting summary
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